Hilde Langseth

Forsker
ved Kreftregisteret - Institutt for populasjonsbasert kreftforskning
Seksjonssjef
ved Kreftregisteret - Institutt for populasjonsbasert kreftforskning 2024 ved Folkehelseinstituttet

Kontaktinformasjon Kontaktinformasjon

21077000

Resultater Resultater

Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case–Control Study in the Janus Serum Bank.

Wu, Zeni; Trabert, Britton; Guillemette, Chantal; Caron, Patrick; Bradwin, Gary; Graubard, Barry I.; Weiderpass Vainio, Elisabete; Ursin, Giske; Langseth, Hilde; McGlynn, Katherine A.. 2023, Cancer Epidemiology, Biomarkers and Prevention. NCI, UL, UoU, UIO, IARC, ICOSTAMUOL, CHB, UOSC, KREFTREGVitenskapelig artikkel

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway.

Turzanski Fortner, Shannon Renee; Trewin-Nybråten, Cassia B.; Paulsen, Torbjørn; Langseth, Hilde. 2023, International Journal of Cancer. DKFZ, ICOSTAMUOL, OUS, KREFTREGVitenskapelig artikkel

Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.

Robsahm, Trude Eid; Tsuruda, Kaitlyn ; Hektoen, Helga; Storås, Anne Marie Holck; Cook, M.B.; Hurwitz, L.M.; Langseth, Hilde. 2023, Acta Oncologica. NCI, ICOSTAMUOL, OUS, KREFTREGVitenskapelig artikkel

Dynamic and static circulating cancer microRNA biomarkers – a validation study.

Abu-Halima, Masood; Keller, Andreas; Becker, Lea Simone; Fischer, Ulrike; Engel, Annika; Ludwig, Nicole; Kern, Fabian; Rounge, Trine Ballestad; Langseth, Hilde; Meese, Eckart mfl.. 2023, RNA Biology. UdS, UIO, ICOSTAMUOL, KREFTREGVitenskapelig artikkel

Pre-diagnostic circulating RNAs in endometrial cancer – impact of body mass index.

Rostami, Sina; Langseth, Hilde; lyle, robert; Bjørge, Tone; Pestarino, Luca; Rounge, Trine Ballestad. 2022, Association of Nordic Cancer Registries (ANCR) Symposium 2022. UIO, OUS, KREFTREG, UIBPoster

1 - 5 av 64 | Neste | Siste »